| 2021-12-14 | Sale | Ikena Oncology, Inc. IKNA | director | 5,959 0.0217% | $14.00 | $83,426 | -63.59% | |
| 2021-12-13 | Sale | Ikena Oncology, Inc. IKNA | director | 8,330 0.0307% | $14.64 | $121,951 | -64.74% | |
| 2021-12-10 | Sale | Ikena Oncology, Inc. IKNA | director | 11,989 0.0457% | $15.03 | $180,195 | -64.33% | |
| 2021-06-28 | Sale | Intellia Therapeutics, Inc. NTLA | director | 553,376 0.8076% | $132.73 | $73.45M | -15.62% | |
| 2021-06-14 | Sale | Intellia Therapeutics, Inc. NTLA | director | 170,779 0.2488% | $87.37 | $14.92M | +28.56% | |
| 2021-06-11 | Sale | Intellia Therapeutics, Inc. NTLA | director | 30,946 0.0454% | $85.23 | $2.64M | +32.88% | |
| 2021-04-29 | Sale | Intellia Therapeutics, Inc. NTLA | director | 4,513 0.0071% | $85.43 | $385,546 | +41.27% | |
| 2021-04-28 | Sale | Intellia Therapeutics, Inc. NTLA | director | 131,926 0.1941% | $85.56 | $11.29M | +32.61% | |
| 2021-04-27 | Sale | Intellia Therapeutics, Inc. NTLA | director | 210,230 0.3054% | $86.22 | $18.13M | +29.94% | |
| 2021-04-26 | Sale | Intellia Therapeutics, Inc. NTLA | director | 806 0.0012% | $84.93 | $68,454 | +33.42% | |
| 2021-04-05 | Sale | Intellia Therapeutics, Inc. NTLA | director | 800 0.0012% | $84.98 | $67,984 | +40.33% | |
| 2021-03-30 | Ikena Oncology, Inc. IKNA | director | 125,000 2.0291% | $16.00 | $2M | -49.34% | ||
| 2021-02-26 | Sale | Intellia Therapeutics, Inc. NTLA | director | 1M 1.4901% | $60.29 | $60.53M | +87.45% | |
| 2018-07-16 | Sale | Intellia Therapeutics, Inc. NTLA | director | 13,372 0.0329% | $31.17 | $416,795 | -43.46% | |
| 2018-06-19 | Sale | Intellia Therapeutics, Inc. NTLA | director | 13,372 0.0301% | $27.96 | $373,816 | -41.17% | |
| 2018-05-16 | Sale | Intellia Therapeutics, Inc. NTLA | director | 13,372 0.0309% | $25.04 | $334,779 | -27.68% | |
| 2018-03-20 | Sale | Intellia Therapeutics, Inc. NTLA | director | 78,490 0.1875% | $23.87 | $1.87M | -7.66% | |
| 2017-11-06 | Spero Therapeutics, Inc. SPRO | director | 428,571 5.3915% | $14.00 | $6M | -3% | ||
| 2017-07-11 | Sale | Intellia Therapeutics, Inc. NTLA | director | 160,000 0.4527% | $16.07 | $2.57M | +39.31% | |
| 2017-07-10 | Sale | Intellia Therapeutics, Inc. NTLA | director | 80,000 0.2289% | $16.17 | $1.29M | +39.73% |